MCID: LYM008
MIFTS: 41

Lymphangiosarcoma malady

Rare diseases, Cancer diseases, Skin diseases, Immune diseases categories

Aliases & Classifications for Lymphangiosarcoma

About this section

Aliases & Descriptions for Lymphangiosarcoma:

Name: Lymphangiosarcoma 10 12 65 36
Skin Lymphangiosarcoma 10 65
Angiosarcoma Associated with Chronic Lymphedema 45
Lymphangiosarcoma of Stewart and Treves 10
Lymphangiosarcoma Following Mastectomy 45
 
Postmastectomy Extremity Angiosarcoma 45
Malignant Lymphangioendothelioma 10
Stewart Treves Syndrome 45
Stewart-Treves Syndrome 10


Classifications:



External Ids:

Disease Ontology10 DOID:2689
MeSH36 D008204
NCIt42 C3205

Summaries for Lymphangiosarcoma

About this section
Wikipedia:68 Lymphangiosarcoma is a rare malignant tumor which occurs in long-standing cases of primary or secondary... more...

MalaCards based summary: Lymphangiosarcoma, also known as skin lymphangiosarcoma, is related to angiosarcoma and lymphedema. An important gene associated with Lymphangiosarcoma is TNF (Tumor Necrosis Factor), and among its related pathways are VEGFR3 signaling in lymphatic endothelium and EBV LMP1 signaling. Affiliated tissues include skin, breast and cervix, and related mouse phenotypes are digestive/alimentary and cardiovascular system.

Related Diseases for Lymphangiosarcoma

About this section

Diseases related to Lymphangiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 108)
idRelated DiseaseScoreTop Affiliating Genes
1angiosarcoma30.8CD34, HBA1
2lymphedema10.8
3cervicitis10.4
4intravascular papillary endothelial hyperplasia10.4
5primary malignant lymphoma10.4
6endotheliitis10.4
7scrotal angioma10.3HBA1, PROX1
8breast cancer10.3
9tufted hair folliculitis10.3FLT4, PROX1
10muscular dystrophy-dystroglycanopathy10.3FLT4, GJC2
11elephantiasis10.3
12sarcoma10.3
13type 2n von willebrand disease10.2F8, VWF
14tyrobp-related polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy10.2F8, VWF
15central epithelioid sarcoma10.2FLT4, GJC2, TNF
16severe hemophilia a10.2F8, VWF
17familial hemangioma10.2F8, VWF
18type 2m von willebrand disease10.2F8, VWF
19listeriosis10.2IFNB1, TNF
20acral dysostosis dyserythropoiesis syndrome10.2F8, VWF
21gallbladder angiosarcoma10.2CD34, HBA1
22extragonadal seminoma10.2HBA1, VEGFA
23periosteal chondrosarcoma10.2CD34, HBA1
24ischemic fasciitis10.2CD34, HBA1
25septal myocardial infarction10.2CD34, HBA1
26ovary serous adenocarcinoma10.2CD34, HBA1
27hemiplegia alterans10.2FLT4, VEGFA
28von willebrand disease, type 110.2F8, VWF
29thyroiditis10.2CD34, HBA1
30fallopian tube mucinous adenocarcinoma10.2CD34, HBA1
31eosinophilic meningitis10.2CD34, HBA1
32tooth ankylosis10.2LYZ, TNF
33barrett's adenocarcinoma10.2CD34, HBA1
34peripheral nervous system ganglioneuroblastoma10.2CD34, DSP
35aorta angiosarcoma10.2CD34, HBA1
36al gazali aziz salem syndrome10.2LYZ, VWF
37hereditary lymphedema10.2
38filariasis10.2
39lymphangioma10.2
40congenital lymphedema10.2
41histiocytoid hemangioma10.2CD34, HBA1
42angiodysplasia10.1CD34, HBA1
43meniere's disease10.1CD34, LYZ
44skin melanoma10.1HBA1, PROX1, VEGFA
45asphyxiating thoracic dystrophy10.1DSP, MNX1, TNF
46microcystic adenoma10.1TNF, VEGFA
47carbohydrate metabolic disorder10.1FLT4, HBA1, VEGFA
48dubowitz syndrome10.1F8, VWF
49angiomatous meningioma10.1CD34, LYZ
50lymphoblastic lymphoma10.1FLT4, GJC2, PROX1, VEGFC

Graphical network of the top 20 diseases related to Lymphangiosarcoma:



Diseases related to lymphangiosarcoma

Symptoms for Lymphangiosarcoma

About this section

Drugs & Therapeutics for Lymphangiosarcoma

About this section

Drugs for Lymphangiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PaclitaxelapprovedPhase 2250533069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
2
FluorouracilapprovedPhase 1193751-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
3
Belinostatapproved, investigationalPhase 137
Synonyms:
Beleodaq
 
Belinostat
PXD 101

Interventional clinical trials:

idNameStatusNCT IDPhase
1Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryRecruitingNCT00217607Phase 2
2Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1

Search NIH Clinical Center for Lymphangiosarcoma


Cochrane evidence based reviews: Lymphangiosarcoma

Genetic Tests for Lymphangiosarcoma

About this section

Anatomical Context for Lymphangiosarcoma

About this section

MalaCards organs/tissues related to Lymphangiosarcoma:

33
Skin, Breast, Cervix, Testes, Lymph node, Bone, Lung

Animal Models for Lymphangiosarcoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Lymphangiosarcoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.0FLT4, MNX1, PDPN, PROX1, TNF, VEGFA
2MP:00053857.0FLT4, LYVE1, MNX1, PDPN, PROX1, TNF
3MP:00107686.4DSP, F8, FLT4, GJC2, HBA1, MNX1
4MP:00053766.1CD34, F8, FLT4, IFNB1, MNX1, PDPN
5MP:00053975.8CD34, F8, GJC2, IFNB1, LYVE1, MNX1
6MP:00053875.0CD34, F8, FLT4, GJC2, IFNB1, LYVE1

Publications for Lymphangiosarcoma

About this section

Articles related to Lymphangiosarcoma:

(show top 50)    (show all 160)
idTitleAuthorsYear
1
Lymphangiosarcoma with systemic metastases in a Japanese domestic cat. (25482607)
2015
2
Stewart-Treves Phenomenon: Lymphangiosarcoma Arising in Lymphedematous Tissue Is Not a Syndrome. (25658055)
2015
3
Lymphangiosarcoma of the scalp. (24342442)
2014
4
Plasma-cell rich lymphangiosarcoma: an under-recognized variant and potential diagnostic pitfall. (22188566)
2012
5
Lymphangiosarcoma of the vocal cord: a rare entity defined by a D2-40 immunohistochemical and ultrastructural study. (20975065)
2011
6
Locally invasive lymphangiosarcoma in a young domestic shorthair. (21880529)
2011
7
Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas. (20459536)
2010
8
Lymphangiosarcoma complicating extensive congenital mixed vascular malformations. (20863270)
2010
9
Lymphangiosarcoma in a 3.5-year-old Bullmastiff bitch with vaginal prolapse, primary lymph node fibrosis and other congenital defects. (16300186)
2005
10
Cutaneous lymphangiosarcoma in a young dog: clinical, anatomopathological and lectinhistochemical description. (15109239)
2003
11
Lymphangiosarcoma in a horse. (10805986)
2000
12
Stewart-Treves syndrome: lymphangiosarcoma following mastectomy. (10651369)
2000
13
Lymphangiosarcoma (Stewart-Treves syndrome) in postmastectomy patients. (11119680)
2000
14
Guess What! Lymphangiosarcoma of Stewart-Treves. (9917177)
1998
15
Lymphangiosarcoma of the pubic region: a rare complication arising in congenital non-hereditary lymphedema. (9854166)
1998
16
Disseminated lymphangiosarcoma in a dog. (8993785)
1997
17
Lymphangiosarcoma in a young dog. (8740713)
1996
18
Lymphedema-induced lymphangiosarcoma. (7720889)
1995
19
Lymphangiosarcoma following mastectomy. (7586817)
1995
20
Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications. (7747790)
1995
21
Lymphangiosarcoma in a dog. (7696420)
1994
22
Lymphangiosarcoma of arm after chronic lymphedema: a rare long-term complication after radical mastectomy in breast cancer patients. Case report and overview. (8503088)
1993
23
Lymphangiosarcoma and haemangiosarcoma in a cat. (2918111)
1989
24
Lymphangiosarcoma of the edematous thigh after radiation therapy for carcinoma of the vulva. (3972297)
1985
25
Lymphangiosarcoma in a dog. (6698882)
1984
26
Electron microscopic observations of lymphangiosarcoma arising from chronic lymphedema. (6624459)
1983
27
Canine angiosarcoma (lymphangiosarcoma). (7467082)
1981
28
Lymphangiosarcoma after filarial infection. (7229182)
1981
29
Chemotherapy for postmastectomy lymphangiosarcoma. (7226038)
1981
30
Lymphangiosarcoma of the anterior abdominal wall: a case report. (6452196)
1980
31
Test and teach number eleven. Diagnosis: post-mastectomy lymphangiosarcoma of Stewart and Treves. (876686)
1977
32
Lymphangiosarcoma arising in congenital lymphedema. (1119828)
1975
33
Lymphatics, lymphedema and lymphangiosarcoma. (1096278)
1975
34
Postmastectomy lymphangiosarcoma-temporary response to cyclophosphamide chemotherapy in 2 cases. (4811506)
1974
35
Angiosarcoma: report of three cases of postmastectomy lymphangiosarcoma and one of hemangiosarcoma. (4734252)
1973
36
Lymphangiographic studies in a case of post-mastectomy lymphangiosarcoma. (5023499)
1972
37
Lymphangiosarcoma. (16811066)
1972
38
Lymphangiosarcoma of the thigh. A case report. (5458277)
1970
39
Lymphangiosarcoma following post-mastectomy lymphedema. (5770234)
1969
40
Lymphangiosarcoma in the lymphedematous extremity. (4964996)
1967
41
Postmastectomy lymphangiosarcoma. (6076125)
1967
42
Therapy of lymphangiosarcoma of the chronically edematous limb. Five-year cure of a patient treated by intra-arterial radioactive yttrium. (4289774)
1967
43
Postmastectomy lymphangiosarcoma in the lymphedematous arm: a review of four cases. (5834725)
1965
44
LYMPHANGIOSARCOMA ARISING IN A CHRONICALLY EDEMATOUS ARM FOLLOWING RADICAL MASTECTOMY. (14270257)
1965
45
Lymphangiosarcoma in postmastectomy lymphedema. (5866201)
1965
46
Lymphangiosarcoma in postmastectomy lymphedematous arm. (13825473)
1959
47
Postmastectomy lymphangiosarcoma in elephantiasis chirurgica; Stewart and Treves syndrome. (13494640)
1957
48
Lymphangiosarcoma in postmastectomy lymphedema: five-year survival with irradiation treatment. (13231047)
1955
49
Lymphangiosarcoma of the arm following radical mastectomy. (13269040)
1955
50
Lymphangiosarcoma in postmastectomy lymphoedema. (13155501)
1954

Variations for Lymphangiosarcoma

About this section

Expression for genes affiliated with Lymphangiosarcoma

About this section
Search GEO for disease gene expression data for Lymphangiosarcoma.

Pathways for genes affiliated with Lymphangiosarcoma

About this section

GO Terms for genes affiliated with Lymphangiosarcoma

About this section

Cellular components related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.5F8, VEGFA, VEGFC, VWF
2external side of plasma membraneGO:00098978.9CD34, PDPN, TNF, VWF
3extracellular regionGO:00055766.9CD34, F8, FLT4, HBA1, IFNB1, LYZ

Biological processes related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

(show all 26)
idNameGO IDScoreTop Affiliating Genes
1lymph vessel developmentGO:000194510.6FLT4, PROX1
2blood coagulation, intrinsic pathwayGO:000759710.3F8, VWF
3vascular endothelial growth factor signaling pathwayGO:003808410.3FLT4, VEGFA
4cellular response to vascular endothelial growth factor stimulusGO:003592410.3FLT4, VEGFA
5positive regulation of protein complex assemblyGO:003133410.3TNF, VEGFA
6positive regulation of protein kinase C signalingGO:009003710.3FLT4, VEGFA
7positive regulation of neuroblast proliferationGO:000205210.2VEGFA, VEGFC
8positive regulation of blood vessel endothelial cell migrationGO:004353610.2VEGFA, VEGFC
9positive regulation of protein autophosphorylationGO:003195410.2VEGFA, VEGFC
10positive regulation of lymphangiogenesisGO:190149210.2VEGFA, VEGFC
11positive regulation of mast cell chemotaxisGO:006075410.2VEGFA, VEGFC
12negative regulation of viral genome replicationGO:004507110.1IFNB1, PROX1, TNF
13induction of positive chemotaxisGO:005093010.0VEGFA, VEGFC
14positive regulation of endothelial cell migrationGO:001059510.0FLT4, PROX1, VEGFA
15humoral immune responseGO:000695910.0IFNB1, MNX1, TNF
16positive regulation of endothelial cell proliferationGO:00019389.9FLT4, PROX1, VEGFA
17positive regulation of cellular component movementGO:00512729.7PDPN, VEGFA
18defense response to bacteriumGO:00427429.7IFNB1, LYZ, TNF
19cell motilityGO:00488709.6CD34, PDPN
20positive regulation of angiogenesisGO:00457669.5CD34, VEGFA, VEGFC
21platelet degranulationGO:00025769.4F8, VEGFA, VEGFC, VWF
22lung developmentGO:00303249.2PDPN, PROX1, VEGFA
23lymphangiogenesisGO:00019469.2FLT4, PDPN, PROX1, VEGFA
24single organismal cell-cell adhesionGO:00163379.1CD34, DSP, PDPN
25platelet activationGO:00301689.0F8, VEGFA, VEGFC, VWF
26blood coagulationGO:00075968.2F8, IFNB1, VEGFA, VEGFC, VWF

Sources for Lymphangiosarcoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet